The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Pre-existing cross-reactive immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins in infection-naive subjects have been described by several studies. In particular, regions of high homology between SARS-CoV-2 and common cold coronaviruses have been highlighted as...
Những tác giả chính: | Murray, SM, Ansari, AM, Frater, J, Klenerman, P, Dunachie, S, Barnes, E, Ogbe, A |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Springer Nature
2022
|
Những quyển sách tương tự
-
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
Bằng: Ward, V, et al.
Được phát hành: (2022) -
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
Bằng: Eleanor Barnes, et al.
Được phát hành: (2022-12-01) -
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
Bằng: Caiqin Hu, et al.
Được phát hành: (2022-09-01) -
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
Bằng: Judith Fraussen
Được phát hành: (2022-03-01) -
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
Bằng: Cecilia Jay, et al.
Được phát hành: (2023-08-01)